Abstract
GLP-1 receptor agonists, initially developed to manage type 2 diabetes, are now widely used for weight loss due to their ability to manage hunger. As their use expands rapidly, nurses need to be informed about these drugs and their impact on various health conditions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
